期刊文献+
共找到96篇文章
< 1 2 5 >
每页显示 20 50 100
Effects of Leptin on Expression of Acyl-coenzymeA:Cholesterol Acyltransferases-1 in Cultured Human Monocyte-macrophages 被引量:6
1
作者 白智峰 成蓓 +3 位作者 余其振 李长运 何平 毛晓波 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第6期563-565,590,共4页
Summary: To investigate the effects of leptin on expression of acyl-coenzymeA:cholesterol acyltransferases-1 (ACAT-1) in monocyte-macrophage differentiation, human monocytic cells (THP-1) were cultured in RPMI 1640 an... Summary: To investigate the effects of leptin on expression of acyl-coenzymeA:cholesterol acyltransferases-1 (ACAT-1) in monocyte-macrophage differentiation, human monocytic cells (THP-1) were cultured in RPMI 1640 and made to differentiate into macrophages under the incubation with phorbol myristate acetate (PMA) for 48 h. The cells were divided into 4 groups according to different intervention factors as follows: MCs cultured in RPMI1640 medium with 10 % FBS for 48 h served as MC group (control group), MCs cultured in medium with serum-free RPMI1640 containing 5 % BSA, 100 nmol/L PMA for 48 h as MP group, MCs cultured in RPMI1640 medium with 10 % FBS, 10 μmol/ml leptin for 48 h as leptin-MC group, and MCs cultured in medium with serum-free RPMI1640 containing 5 % BSA, 100 nmol/L PMA, and 10 μmol/ml leptin for 48 h as leptin-MP group. Immunocytochemistry, reverse transcription polymerase chain reaction (RT-PCR) and Western blot were performed, respectively, to observe the effects of leptin on expression of ACAT-1 in the monocyte-macrophage differentiation. Our results showed that expression of ACAT-1 protein and mRNA in MP-group is two times that in MC-group (P<0.05), and the expression of ACAT-1 protein and mRNA increased by up to 4 folds in leptin-MP group as compared with that of MC group (P<0.01). Thus, our results support the idea that expression of ACAT-1 increases more in cultured human macrophages than in monocytes, and leptin can significantly promote ACAT-1 expression. It was concluded that high expression of ACAT-1 may accelerate the development of human atherogenesis,and leptin might participate in atherogenesis by increasing expression of ACAT-1. 展开更多
关键词 acyl-coa:cholesterol acyltransferases-1 MONOCYTE macrophage
下载PDF
Regulation of Acyl-coenzyme A:Cholesterol Acyltransferase 2 Expression by Saturated Fatty Acids 被引量:4
2
作者 Zhu-qin Zhang Hou-zao Chen Rui-feng Yang Ran Zhang Yu-yan Jia Yang Xi De-pei Liu Chih-chuan Liang 《Chinese Medical Sciences Journal》 CAS CSCD 2010年第4期222-227,共6页
Objective To verify the regulation of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT 2), which is associated with cholesterol metabolism, by saturated fatty acids (SFAs). Methods Palmitic acid (PA), the most abun... Objective To verify the regulation of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT 2), which is associated with cholesterol metabolism, by saturated fatty acids (SFAs). Methods Palmitic acid (PA), the most abundant saturated fatty acid in plasma, and oleic acid (OA), a widely distributed unsaturated fatty acid, were used to treat hepatic cells HepG2, HuH7, and mouse primary hepatocytes. In addition, PA at different concentrations and PA treatment at different durations were applied in HepG2 cells. In in vivo experiment, three-month male C57/BL6 mice were fed with control diet and SFA diet containing hydrogenated coconut oil rich of SFAs. The mRNA level of ACAT2 in those hepatic cells and the mouse livers was detected with real-time polymerase chain reaction (PCR). Results In the three types of hepatic cells treated with PA, that SFA induced significant increase of ACAT2 expression (P<0.01), whereas treatment with OA showed no significant effect. That effect of PA was noticed gradually rising along with the increase of PA concentration and the extension of PA treatment duration (both P<0.05). SFA diet feeding in mice resulted in a short-term and transient increase of ACAT2 expression in vivo, with a peak level appearing in the mice fed with SFA diet for two days (P<0.05). Conclusion SFA may regulate ACAT2 expression in human and mouse hepatic cells and in mouse livers. 展开更多
关键词 acyl-coenzyme A:cholesterol acyltransferase 2 gene expression saturatedfatty acid
下载PDF
Lipids-induced Apoptosis Is Aggravated by Acyl-coenzyme A:Cholesterol Acyltransferase Inhibitor
3
作者 Jian-ling Tao Xiong-zhong Ruan +2 位作者 Hang Li Xue-mei Li Xue-wang Li 《Chinese Medical Sciences Journal》 CAS CSCD 2010年第2期76-84,共9页
Objective To investigate the role of acyl-coenzyme A:cholesterol acyltransferase inhibitor(ACATI) in apoptosis induced by lipids and whether lipids-induced apoptosis is accompanied by increase of free cholesterol in e... Objective To investigate the role of acyl-coenzyme A:cholesterol acyltransferase inhibitor(ACATI) in apoptosis induced by lipids and whether lipids-induced apoptosis is accompanied by increase of free cholesterol in endoplasmic reticulum(ER),in order to further understand the mechanism of lipids-induced apoptosis in advanced atherosclerosis.Methods Human vascular smooth muscle cells(VSMCs) and phorbol 12-myristate 13-acetate(PMA) differentiated THP-1 macrophages were used.Tritiated thymidine incorporation was applied to detect cell proliferation.Cytotoxicity was assessed by lactate dehydrogenase(LDH) release.4',6-diamidino-2-phenylindole(DAPI) staining,caspase-3,-7 assay,and Annexin-V/propidium iodide(PI) staining were used to detect apoptosis.High performance liquid chromatography was used in intracellular free cholesterol and cholesterol ester assay.ER free cholesterol was quantified.Results Different lipids had different effects on proliferation and cytotoxicity of VSMCs.25-hydroxycholesterol(25OHC) had biphasic effects on the proliferation of VSMCs.At low concentration,it stimulated cell proliferation,but turned to proliferation inhibition as concentration reached 15 μg/mL.25OHC and acetylated low density lipoprotein(AcLDL) could respectively induce apoptosis in human VSMCs and PMA differentiated THP-1 macrophages,which was aggravated by ACATI,accompanied by increase of intracellular free cholesterol content.There was also an increase of cholesterol content in ER with AcLDL-induced apoptosis in THP-1 macrophages.Conclusions Lipids could induce apoptosis,accompanied by increase of intracellular free cholesterol content,which could be augmented by ACATI,suggesting that insults resulting in ER free cholesterol rise might be the initiator of apoptosis. 展开更多
关键词 APOPTOSIS ATHEROSCLEROSIS acyl-coenzyme A:cholesterol acyltransferase
下载PDF
Effect of Tumor Necrosis Factor-α on Acyl Coenzyme A: Cholesteryl Acyltransferase Activity and ACAT1 Gene Expression in THP-1 Macrophages 被引量:1
4
作者 何平 成蓓 +1 位作者 王毅 王洪星 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2007年第2期170-172,共3页
In order to explore the effect and mechanisms of tumor necrosis factor-α (TNF-α) on the activity of the acyl coenzyme A: cholesteryl acyltransferase (ACAT), THP-I monocytes were cul- tured and induced to differ... In order to explore the effect and mechanisms of tumor necrosis factor-α (TNF-α) on the activity of the acyl coenzyme A: cholesteryl acyltransferase (ACAT), THP-I monocytes were cul- tured and induced to differentiate into macrophages with phorbol ester. TNF-α (60 ng/mL) was added at different time points into the macrophage-containing medium and the ACAT enzyme activity was measured by quantifying the incorporation of [1-^14C] oleoyl CoA into cholesteryl esters. The expression of ACAT-1 protein and mRNA was respectively detected by Western blotting and RT-PCR in THP-1 macrophages 24 h after treatment with TNF-α (60 ng/mL). The results indicated that ACAT activity in THP-I macrophages treated with TNF-α was increased in a time-dependent manner. The expression levels of ACAT-1 protein and mRNA were significantly increased in THP-I macrophages after treatment with TNF-α (P〈0.05). It was suggested that TNF-α could increase the activity of ACAT in THP-1 macrophages by up-regulating the expression of ACAT-1 gene. 展开更多
关键词 acyl coenzyme A: cholesteryl acyltransferase tumor necrosis factor-α MACROPHAGES cholesterol ATHEROSCLEROSIS
下载PDF
酯化酶甾醇O-酰基转移酶1在恶性肿瘤中作用的研究进展
5
作者 王亮 黄幼生 +1 位作者 符谨诚 邹科见 《中国医药》 2024年第1期142-145,共4页
甾醇O-酰基转移酶1(SOAT1)是一种位于内质网内的酯化酶,催化细胞内游离胆固醇转化为脂滴。SOAT1被发现在多种恶性肿瘤内高表达,并与恶性肿瘤增殖、侵袭迁移紧密相关。这表明SOAT1有潜力成为恶性肿瘤早期诊断的生物标志物和治疗新靶点。... 甾醇O-酰基转移酶1(SOAT1)是一种位于内质网内的酯化酶,催化细胞内游离胆固醇转化为脂滴。SOAT1被发现在多种恶性肿瘤内高表达,并与恶性肿瘤增殖、侵袭迁移紧密相关。这表明SOAT1有潜力成为恶性肿瘤早期诊断的生物标志物和治疗新靶点。本文就SOAT1的结构、功能及其在恶性肿瘤中作用的相关研究进展进行综述。 展开更多
关键词 恶性肿瘤 甾醇O-酰基转移酶1 胆固醇 研究进展
下载PDF
靶向胆固醇稳态小分子药物治疗胶质瘤的研究进展
6
作者 姜伟 王君萍 +5 位作者 周鹏 黄玲玲 张梅 陈学冉 王宏志 方志友 《安徽医药》 CAS 2024年第1期11-16,共6页
胶质母细胞瘤(GBM)是成人中最具有侵袭性的恶性脑肿瘤。胆固醇是细胞的必要组分,胆固醇的合成、转运和代谢异常在肿瘤的发生发展过程中起着非常重要作用。胆固醇代谢稳态相关调控因子如尼曼-匹克样C型蛋白(NPC1)、甾醇O-酰基转移酶(SO⁃A... 胶质母细胞瘤(GBM)是成人中最具有侵袭性的恶性脑肿瘤。胆固醇是细胞的必要组分,胆固醇的合成、转运和代谢异常在肿瘤的发生发展过程中起着非常重要作用。胆固醇代谢稳态相关调控因子如尼曼-匹克样C型蛋白(NPC1)、甾醇O-酰基转移酶(SO⁃AT1)已成为肿瘤治疗中潜在的新药物干预靶点。该研究阐述了部分靶向胆固醇稳态的小分子药物可能对GBM的治疗作用。 展开更多
关键词 抗代谢药 抗肿瘤 胶质母细胞瘤 脂类代谢 尼曼-匹克样C型蛋白(NPC1) 甾醇O-酰基转移酶(SOAT1) 胆固醇 合成 转运 小分子药物
下载PDF
胆固醇酰基转移酶1在非小细胞肺癌患者中的表达水平及其与肿瘤分期、病理分级的关系
7
作者 杨婧如 毕明宏 《中国现代医药杂志》 2024年第10期8-12,共5页
目的研究胆固醇酰基转移酶1(ACAT1)在非小细胞肺癌(NSCLC)患者中的表达水平及其与肿瘤分期、病理分级的关系。方法选择2022年1月~2024年1月我院58例NSCLC患者的癌组织标本作为研究组,随机抽取其中20例的癌旁组织标本作为对照组。测试两... 目的研究胆固醇酰基转移酶1(ACAT1)在非小细胞肺癌(NSCLC)患者中的表达水平及其与肿瘤分期、病理分级的关系。方法选择2022年1月~2024年1月我院58例NSCLC患者的癌组织标本作为研究组,随机抽取其中20例的癌旁组织标本作为对照组。测试两组标本中ACAT1表达水平,分析ACAT1在NSCLC患者中的表达水平及其与肿瘤分期、病理分级的关系。结果研究组和对照组之间ACAT1 mRNA表达水平的差异具有统计学意义(P<0.05);高表达组和低表达组患者的年龄、性别、吸烟史差异无统计学意义(P>0.05);高表达组和低表达组患者的肿瘤大小、淋巴结转移、远处转移差异具有统计学意义(P<0.05);高表达组和低表达组患者在肿瘤分期和病理分级上差异有统计学意义(P<0.05);ACAT1 mRNA表达水平与肿瘤分期、病理分级之间均呈正相关(P<0.05);ACAT1与肿瘤大小、淋巴结转移、远处转移、肿瘤分期、病理分级有关(P<0.05)。结论ACAT1 mRNA在NSCLC中的表达水平与肿瘤分期和病理分级密切相关。 展开更多
关键词 胆固醇酰基转移酶1 非小细胞肺癌 表达水平 肿瘤分期 病理分级
下载PDF
Conjugated Linoleic Acid and Dietary Fats Differentially Affect Hepatic ACAT Activity and LDL-Cholesterol in Postweanling Pigs Fed Low-Fat Diets
8
作者 S.B.Smith T.A.Wilson +2 位作者 C.D.Gilbert D.R.Smith H.J.Mersmann 《Journal of Animal Science and Biotechnology》 SCIE CAS 2010年第2期75-84,共10页
ABSTRACT:Two separate studies tested the hypoth- esis that plasma low-density lipoprotein cholesterol LDL-C ) can be decreased by conjugated linoleic acid (CLA) by depressing hepatic acyl-coenzyme A: cholesterol... ABSTRACT:Two separate studies tested the hypoth- esis that plasma low-density lipoprotein cholesterol LDL-C ) can be decreased by conjugated linoleic acid (CLA) by depressing hepatic acyl-coenzyme A: cholesterol acyltransferase (ACAT) activity. In the first experiment, 3 groups of 6 early-weaned piglets were fed low-fat diets containing either 1.5% CLA, 1.5% corn oil or 1.5% beef tallow;fat provided 8% of the energy intake. In the second experiment, 4 groups of 6 early-weaned piglets were fed high-fat di- ets containing either 15% beef tallow, 12% beef tal- low plus 3% CLA, 15% corn oil, or 12% corn oil plus 3% CLA; fat provided 29% of energy intake. Cholesterol was balanced across diets in both experi-ments. In pigs fed the low-fat diets, all dietary fats in- creased LDL-C and triacylglycerols and decreased high-density lipoprotein cholesterol ( HDL-C ) and very low-density lipoprotein cholesterol (VLDL-C). LDL-C was the same in pigs fed low-fat tallow or low-fat CLA diets. However, ACAT activity was near- ly 80% higher in pigs fed the low-fat tallow diet than in pigs fed the low-fat CLA diets. All high-fat diets increased LDL-C, HDL-C and triacylglycerols equally with no effect on VLDL-C. There were no unique fat- ty acid effects of the high-fat diets on ACAT activity. We conclude that supplemental fats had differential effects on hepatic ACAT activity and LDL-C, but on- ly in pigs fed low-fat diets. 展开更多
关键词 acyl-coenzyme A: cholesterol acyltransferase conjugated linoleic acid fatty acids liver PIGS
下载PDF
ACAT-1 rs1044925单核苷酸多态性与急性冠脉综合征及阿托伐他汀治疗后血脂反应的关系研究 被引量:2
9
作者 王舟 邓金龙 吴东峰 《中国全科医学》 CAS 北大核心 2023年第21期2620-2625,共6页
背景 既往研究显示ACAT-1 rs1044925单核苷酸多态性(SNP)与冠心病及缺血性脑卒中的发病风险相关,并且与血脂水平有关。目的 本研究旨在探讨ACAT-1 rs1044925 SNP与急性冠脉综合征(ACS)的关系,以及rs1044925 SNP与ACS患者阿托伐他汀治疗... 背景 既往研究显示ACAT-1 rs1044925单核苷酸多态性(SNP)与冠心病及缺血性脑卒中的发病风险相关,并且与血脂水平有关。目的 本研究旨在探讨ACAT-1 rs1044925 SNP与急性冠脉综合征(ACS)的关系,以及rs1044925 SNP与ACS患者阿托伐他汀治疗后调脂效果的关系。方法 选择2016年1月—2018年1月在广西壮族自治区人民医院老年心血管内科确诊为ACS并接受经皮冠状动脉介入治疗(PCI)的患者111例作为ACS组(男67例,女44例);患者均接受阿托伐他汀治疗,20 mg/晚;同时服用氯吡格雷75 mg,1次/d(或替格瑞洛90 mg,2次/d),阿司匹林100 mg,1次/d;并在经PCI后常规使用阿托伐他汀,20 mg/晚。对照组为同期体检健康人群,共338例(男170例,女168例)。通过聚合酶链反应和限制性片段长度多态性(PCR-RFLP)对ACAT-1 rs1044925 SNP进行基因分型,检测ACS组和对照组的基线血脂水平,随访检测ACS组患者阿托伐他汀治疗1年后血脂参数。结果 ACS组和对照组受检者的血清总胆固醇(TC)间差异无统计学意义(P>0.05),而三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白AI(ApoAI)、载脂蛋白B(ApoB)水平间差异均有统计学意义(P<0.05)。ACS组和对照组的ACAT-1 rs1044925 SNP基因型及等位基因频率的分布间差异均无统计学意义(P>0.05)。对照组ACAT-1 rs1044925 SNP的各基因型间TC、TG、HDL-C、LDL-C、ApoAI及ApoB水平比较,差异无统计学意义(P>0.05)。阿托伐他汀治疗后,ACS患者血清TC、LDL-C、ApoAI、ApoB及脂蛋白α[Lp(α)]水平与基线水平比较,差异均有统计学意义(P<0.05)。ACS组各基因型患者间的基线及1年后的TC、TG、HDL-C、LDL-C、ApoAI、ApoB水平比较,差异均无统计学意义(P>0.05);ACS组不同基因型患者间的基线Lp(α)水平差异无统计学意义(P>0.05),而治疗1年后,各基因型患者间的Lp(α)水平比较,差异有统计学意义(P<0.05)。AA基因型患者治疗后的TC、LDL-C、ApoAI、ApoB、Lp(α)水平与基线水平比较,以及AC/CC基因型患者治疗后的TC、LDL-C、ApoB水平与基线水平比较,差异均有统计学意义(P<0.05),不同基因型患者间阿托伐他汀治疗后TC、LDL-C、ApoB水平降低程度和ApoAI升高程度比较,差异无统计学意义(P>0.05),不同基因型患者间阿托伐他汀治疗后Lp(α)水平降低程度比较,差异有统计学意义(P<0.05)。结论 ACAT-1 rs1044925 SNP与ACS没有明显关联,ACS患者接受阿托伐他汀治疗后,rs1044925 SNP AA基因型患者较AC/CC基因型患者Lp(α)降低更明显。 展开更多
关键词 急性冠状动脉综合征 胆固醇酰基转移酶1 ACAT-1 rs1044925 单核苷酸多态性 阿托伐他汀 血脂
下载PDF
颈动脉粥样硬化斑块患者外周血LCAT基因启动子区DNA甲基化情况观察
10
作者 赵佳 姜小建 +2 位作者 谢紫阳 屈晓艳 左林 《山东医药》 CAS 2023年第24期21-24,共4页
目的观察颈动脉粥样硬化斑块患者外周血卵磷脂胆固醇酰基转移酶(LCAT)基因启动子区DNA甲基化情况。方法颈动脉粥样硬化斑块患者52例(观察组),同期无颈动脉粥样硬化斑块健康体检者50例(对照组),对所有受试者进行LCAT基因启动子区DNA甲基... 目的观察颈动脉粥样硬化斑块患者外周血卵磷脂胆固醇酰基转移酶(LCAT)基因启动子区DNA甲基化情况。方法颈动脉粥样硬化斑块患者52例(观察组),同期无颈动脉粥样硬化斑块健康体检者50例(对照组),对所有受试者进行LCAT基因启动子区DNA甲基化检测,比较两组甲基化占比;对观察组患者进行头颈部CT血管成像(CTA)检查,比较观察组甲基化患者和非甲基化患者血管狭窄情况。结果观察组外周血LCAT基因启动子区DNA甲基化占比为65.38%(34/52),对照组外周血LCAT基因启动子区DNA甲基化占比为36.00%(18/50),两组甲基化占比比较,P<0.05。观察组34例甲基化患者中,颈动脉轻中度狭窄21例、重度及闭塞13例;观察组18例非甲基化患者中,颈动脉轻中度狭窄16例、重度及闭塞2例;观察组甲基化患者与非甲基化患者颈动脉狭窄严重程度比较,P均<0.05。结论颈动脉粥样硬化斑块患者外周血LCAT基因启动子区DNA甲基化占比高,LCAT基因启动子区DNA甲基化与动脉粥样硬化斑块的密切相关。 展开更多
关键词 动脉粥样硬化 卵磷脂胆固醇酰基转移酶 DNA甲基化 颈动脉狭窄程度
下载PDF
Acyl-coenzyme A: cholesterol acyltransferase family
11
作者 Yali LIU Zhanyun GUO 《Frontiers in Biology》 CSCD 2009年第2期129-136,共8页
The enzymes of the acyl-coenzyme A:cholesterol acyltransferase(ACAT)family are responsible for the in vivo synthesis of neutral lipids.They are potential drug targets for the intervention of atherosclerosis,hyperlipid... The enzymes of the acyl-coenzyme A:cholesterol acyltransferase(ACAT)family are responsible for the in vivo synthesis of neutral lipids.They are potential drug targets for the intervention of atherosclerosis,hyperlipidemia,obesity,type II diabetes and even Alzheimer’s disease.ACAT family enzymes are integral endoplasmic reticulum(ER)membrane proteins and can be divided into ACAT branch and acyl-coenzyme A:diacylglycerol acyltransferase 1(DGAT1)branch according to their substrate specificity.The ACAT branch catalyzes synthesis of cholesteryl esters using long-chain fatty acyl-coenzyme A and cholesterol as substrates,while the DGAT1 branch catalyzes synthesis of triacylglycerols using fatty acylcoenzyme A and diacylglycerol as substrates.In this review,we mainly focus on the recent progress in the structural research of ACAT family enzymes,including their disulfide linkage,membrane topology,subunit interaction and catalysis mechanism. 展开更多
关键词 LIPID acyl-coenzyme A:cholesterol acyltransferase(ACAT) acyl-coenzyme A:diacylglycerol acyltransferase 1(DGAT1) acyltransferase CATALYSIS
原文传递
Effect of Astragalus Angelica Mixture(黄芪当归合剂)on Lipoprotein Lipase and Lecithin Cholesterol Acyltransferase of Nephrotic Rats
12
作者 李宁军 李惊子 +3 位作者 辛岗 许远 洪健美 王海燕 《Chinese Journal of Integrative Medicine》 SCIE CAS 1999年第4期287-287,共1页
关键词 Effect of Astragalus Angelica Mixture on Lipoprotein Lipase and Lecithin cholesterol acyltransferase of Nephrotic Rats
原文传递
Effect of Astragalus-Angelica Mixture on Lipoprotein Lipase and Lecithin-Cholesterol Acyltransferase of Nephrotic Rats
13
作者 李宁军 李惊子 +3 位作者 辛岗 许远 洪健美 王海燕 《Chinese Journal of Integrative Medicine》 SCIE CAS 2000年第1期35-37,共3页
Objective: To investigate the mechanism of Astragalus-Angelica Mixture (AAM) ’s effects on lipid metabolism disturbance in nephrotic rats.Methods: To examine the effects of AAM on serum albumin, lipid levels, and act... Objective: To investigate the mechanism of Astragalus-Angelica Mixture (AAM) ’s effects on lipid metabolism disturbance in nephrotic rats.Methods: To examine the effects of AAM on serum albumin, lipid levels, and activities of lipoprotein lipase (LPL) and lecithin-cholesterol acyltransferase (LCAT), which are key enzymes for metabolism of lipid in immune-induced nephrotic hyperlipidemia rats and exogenous hyperlipidemia rats.Results: In nephrotic rats, serum albumin was reduced, lipid increased significantly, LPL activity decreased markedly and the LCAT activity was relatively insufficient. Activities of LPL and LCAT increased obviously in AAM treated nephrotic rats. There were no change of activities of LPL and LCAT in exogenous hyperlipidemia rats and AAM showed no effect on the activities of these two enzymes.Conclusion: The effect of AAM on regulating lipid metabolism might be due to enhance the clearance of both triglyceride-rich and cholesterol-rich apoB containing lipoprotein by improving the activities of LPL and LCAT. 展开更多
关键词 Astragalus-Angelica Mixture nephrotic syndrome lipoprotein lipase lecithin-cholesterol acyltransferase HYPERLIPIDEMIA
原文传递
黄芪当归合剂对肾病综合征大鼠脂蛋白脂酶和卵磷脂胆固醇酰基转移酶的影响 被引量:91
14
作者 李宁军 李惊子 +3 位作者 辛岗 许远 洪健美 王海燕 《中国中西医结合杂志》 CAS CSCD 北大核心 1999年第8期484-486,共3页
目的:探讨黄芪当归合剂(合剂)调节脂代谢紊乱的可能机理。方法:在肾病综合征(NS)高脂血症及高胆固醇血症大鼠,观察合剂对血清白蛋白、血脂及脂质降解的两个关键酶脂蛋白脂酶(LPL)和卵磷脂胆固醇酰基转移酶(LCAT)活... 目的:探讨黄芪当归合剂(合剂)调节脂代谢紊乱的可能机理。方法:在肾病综合征(NS)高脂血症及高胆固醇血症大鼠,观察合剂对血清白蛋白、血脂及脂质降解的两个关键酶脂蛋白脂酶(LPL)和卵磷脂胆固醇酰基转移酶(LCAT)活性的影响。结果:NS大鼠出现明显低白蛋白、高脂血症,同时LPL活性降低,LCAT活性相对不足;在NS大鼠应用合剂治疗后,不仅血清白蛋白明显升高、血脂明显下降,LPL及LCAT活性亦明显增加;高胆固醇血症时LPL及LCAT活性无明显改变,合剂对其活性亦无影响。结论:NS大鼠LPL活性降低,LCAT活性相对不足是其高脂血症发生机理之一。合剂通过增加LPL和LCAT活性,促进循环中含载脂蛋白B(apoB)。 展开更多
关键词 黄芪当归合剂 肾病综合征 脂蛋白脂酶 治疗
下载PDF
干扰素-γ对单核—巨噬细胞源性泡沫细胞ACAT-1表达的影响 被引量:8
15
作者 柯丽 成蓓 +2 位作者 余其振 何平 白智峰 《山东医药》 CAS 北大核心 2005年第10期14-15,共2页
目的观察干扰素-γ对THP-1、THP-1源性巨噬细胞泡沫细胞酰基辅酶A胆固醇酰基转移酶-1(ACAT-1)表达的影响。方法将THP-1细胞与PMA孵育48小时使之分化为巨噬细胞,继以100mg/mlOx-LDL处理24小时使之形成泡沫细胞。将THP-1细胞、巨噬细胞、... 目的观察干扰素-γ对THP-1、THP-1源性巨噬细胞泡沫细胞酰基辅酶A胆固醇酰基转移酶-1(ACAT-1)表达的影响。方法将THP-1细胞与PMA孵育48小时使之分化为巨噬细胞,继以100mg/mlOx-LDL处理24小时使之形成泡沫细胞。将THP-1细胞、巨噬细胞、泡沫细胞分别用300U/mlIFN-γ干预24小时。RT-PCR检测ACAT-1mRNA水平,WesternBlot检测其蛋白表达。结果THP-1细胞分化成巨噬细胞以及形成泡沫细胞时ACAT-1mRNA及蛋白含量增加(P<0.05),而后两种细胞之间无显著性差异。与各自的对照组相比,经IFN-γ作用后三种细胞ACAT-1mRNA及蛋白表达均增强(P<0.05)。结论IFN-γ诱导单核、巨噬细胞、泡沫细胞ACAT-1的mRNA及蛋白表达,这可能是其促进动脉粥样硬化的机制之一。 展开更多
关键词 泡沫细胞 干扰素-Γ 细胞源性 单核 THP-1细胞 胆固醇酰基转移酶 RT-PCR检测 IFN-γ Western 巨噬细胞 mRNA水平 蛋白表达 BLOT检测 动脉粥样硬化 酰基辅酶A OxLDL 显著性差异 细胞分化 蛋白含量 种细胞 PMA 对照组
下载PDF
姜黄素对食饵性高脂血症大鼠血浆脂蛋白代谢相关酶活性的影响 被引量:81
16
作者 沃兴德 崔小强 唐利华 《中国动脉硬化杂志》 CAS CSCD 2003年第3期223-226,共4页
为了探讨姜黄素降血脂、抗动脉粥样硬化可能的酶学机理 ,用高脂膳食喂饲Wistar大鼠 4周 ,造成食饵性高脂血症 ,然后用高、低两种剂量的姜黄素和阳性对照药血脂康、非诺贝特进行实验性治疗。给药 3周后处死动物 ,比较治疗前后血清和肝脏... 为了探讨姜黄素降血脂、抗动脉粥样硬化可能的酶学机理 ,用高脂膳食喂饲Wistar大鼠 4周 ,造成食饵性高脂血症 ,然后用高、低两种剂量的姜黄素和阳性对照药血脂康、非诺贝特进行实验性治疗。给药 3周后处死动物 ,比较治疗前后血清和肝脏总胆固醇及甘油三酯含量、血清高密度脂蛋白胆固醇和低密度脂蛋白胆固醇含量 ,同时测定血浆卵磷脂胆固醇酰基转移酶、肝素化血浆总脂解酶、脂蛋白脂酶和肝脂酶活性。结果发现 ,高、低剂量姜黄素、非诺贝特和血脂康均能使血清总胆固醇、甘油三酯和低密度脂蛋白胆固醇含量降低 ,降甘油三酯作用高剂量姜黄素和非诺贝特最优 ,降总胆固醇和低密度脂蛋白胆固醇作用低剂量姜黄素和血脂康最优 ,高剂量姜黄素和非诺贝特能增加高密度脂蛋白胆固醇含量 ,同时能降低肝脏总胆固醇和甘油三酯含量。高、低剂量姜黄素能显著提高血浆卵磷脂胆固醇酰基转移酶活性 ,降低血浆游离胆固醇含量 ,高、低剂量姜黄素和非诺贝特能提高血浆总脂解酶和脂蛋白脂酶活性 ,高剂量姜黄素还能显著提高肝脂酶活性。结果提示 ,姜黄素具有明显的降低肝脏和血清脂质的作用 。 展开更多
关键词 姜黄素 血浆脂蛋白代谢相关酶 活性 食饵性高脂血症 大鼠 卵磷脂胆固醇酰基转移酶 脂蛋白脂酶 肝脂酶
下载PDF
冠心病患者血浆LCAT水平与HDL亚类组成的关系 被引量:16
17
作者 丁岚 田英 +5 位作者 林国平 陈志军 张彩平 王小鸥 陈浩 龙石银 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第7期1244-1249,共6页
目的:探讨冠心病(coronary heart disease,CHD)患者血浆卵磷脂胆固醇酰基转移酶(lecithin cholesterol acyltransferase,LCAT)与高密度脂蛋白(high-density lipoprotein,HDL)亚类分布的关系。方法:采用双向电泳-免疫印记法分析了73例正... 目的:探讨冠心病(coronary heart disease,CHD)患者血浆卵磷脂胆固醇酰基转移酶(lecithin cholesterol acyltransferase,LCAT)与高密度脂蛋白(high-density lipoprotein,HDL)亚类分布的关系。方法:采用双向电泳-免疫印记法分析了73例正常对照者和144例冠心病患者HDL亚类的组成、含量及分布特征,用酶联免疫法测定其LCAT浓度。冠心病患者按血浆LCAT浓度进行四分位数(19.22、36.39和55.32 mg/L)分层(Q1:LCAT<19.22 mg/L;Q2:19.22≤LCAT<36.39 mg/L;Q3:36.39≤LCAT<55.32 mg/L;Q4:LCAT≥55.32 mg/L)。结果:随着LCAT浓度的降低,冠心病患者血浆总胆固醇(TC)、甘油三酯(TG)水平和载脂蛋白B-100/A-I(apoB-100/A-I)比值呈增加趋势,高密度脂蛋白胆固醇(HDL-C)和apoA-I水平呈减少趋势。与最高四分位数组相比,第三、第二和最低四分位数组中preβ1-HDL含量增加,HDL2a和HDL2b含量减少(P<0.05或P<0.01)。与正常TC组比较,高TC组LCAT浓度降低,且preβ1-HDL含量增加,HDL2a和HDL2b含量减少(P<0.01)。直线相关和多元回归分析中发现,血浆LCAT水平与preβ1-HDL浓度呈负相关,与HDL2a和HDL2b浓度呈正相关。结论:CHD患者血浆HDL颗粒呈变小趋势,并且随着LCAT水平的降低,其HDL颗粒的变小程度更加明显。 展开更多
关键词 高密度脂蛋白类 卵磷脂胆固醇酰基转移酶 动脉粥样硬化 冠心病
下载PDF
ABCA1、ACAT1 DNA甲基化在Hcy致THP-1单核源性泡沫细胞胆固醇流出中作用研究 被引量:9
18
作者 杨安宁 王磊 +8 位作者 周龙霞 赵丽 王艳华 蔡欣 曹成建 杨程 陈久凯 马文斌 姜怡邓 《中国药理学通报》 CAS CSCD 北大核心 2014年第3期44-48,共5页
目的探讨ABCA1、ACAT1 DNA甲基化在同型半胱氨酸(Hcy)致THP-1单核源性泡沫细胞胆固醇流出中的作用。方法复制泡沫细胞模型,用50、100、200、500μmol·L-1Hcy和100μmol·L-1Hcy+叶酸+维生素B12(100+F+V)干预,并设对照组(0μmol... 目的探讨ABCA1、ACAT1 DNA甲基化在同型半胱氨酸(Hcy)致THP-1单核源性泡沫细胞胆固醇流出中的作用。方法复制泡沫细胞模型,用50、100、200、500μmol·L-1Hcy和100μmol·L-1Hcy+叶酸+维生素B12(100+F+V)干预,并设对照组(0μmol·L-1Hcy)。油红O染色观察泡沫细胞形成,巢式降落式甲基化特异性PCR(nMS-PCR)检测ABCA1、ACAT1 DNA甲基化水平,并分析两者比值变化;ELISA-like法检测DNA甲基转移酶(DNMTs)活性;化学比色法分析细胞内胆固醇含量。结果成功复制了泡沫细胞模型;给予不同浓度Hcy刺激后,ABCA1 DNA甲基化改变呈上升趋势,ACAT1 DNA甲基化改变呈下降趋势,给予100+F+V干预后可逆转上述变化,其中ABCA1 DNA甲基化改变更明显;同时,不同浓度Hcy可使泡沫细胞内DNMTs活性和胆固醇含量增加。结论 ABCA1和ACAT1 DNA甲基化的改变参与了Hcy致THP-1单核源性泡沫细胞胆固醇流出,DNMTs可能起关键调控作用。 展开更多
关键词 同型半胱氨酸 泡沫细胞 三磷酸腺苷-结合转运子A1 酰基辅酶A 胆固醇酰基转移酶1 DNA甲基化 胆固醇流出
下载PDF
纳米蜂胶对实验性高脂血症大鼠脂质代谢的影响 被引量:10
19
作者 李雅晶 冯磊 +2 位作者 胡福良 张挺 陈民利 《中国药学杂志》 CAS CSCD 北大核心 2007年第12期903-906,共4页
目的探讨纳米蜂胶对实验性高脂血症大鼠脂质代谢的影响。方法采用动物实验法,观察不同剂量纳米蜂胶对高脂血症大鼠体重、肝重、血清总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)浓度及脂蛋白脂酶(LPL)、肝脂酶(... 目的探讨纳米蜂胶对实验性高脂血症大鼠脂质代谢的影响。方法采用动物实验法,观察不同剂量纳米蜂胶对高脂血症大鼠体重、肝重、血清总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)浓度及脂蛋白脂酶(LPL)、肝脂酶(HL)、卵磷脂胆固醇酰基转移酶(LCAT)活性的影响。结果纳米蜂胶对高脂血症大鼠的体重、肝重及HDL-C含量无显著影响,但各剂量组纳米蜂胶均可显著提高LPL、HL的活力(P<0.01,P<0.05),中、高剂量纳米蜂胶可显著降低血清TC值和显著提高LCAT活力(P<0.05,P<0.01),高剂量组纳米蜂胶可使LDL-C含量、肝指数和动脉硬化指数(AI)显著下降(P<0.05)。结论纳米蜂胶具有明显降低血清胆固醇的作用,可能与提高血酯蛋白相关酶活性有关。 展开更多
关键词 纳米蜂胶 高脂血症 脂蛋白脂酶 肝脂酶 卵磷脂胆固醇酰基转移酶 脂质代谢
下载PDF
银杏叶提取物EGB761对阿尔茨海默病家兔模型ACAT1和LCAT mRNA表达的影响 被引量:8
20
作者 姜希娟 卢斌 +5 位作者 马东明 郭茂娟 杨琳 张瑞峰 王强 范英昌 《天津中医药》 CAS 2011年第1期59-60,共2页
[目的]观察银杏叶提取物EGB761对阿尔茨海默(AD)病家兔模型胆固醇酰基转移酶(ACAT1)和卵磷脂-胆固醇酰基转移酶(LCAT)mRNA表达的影响。[方法]以2%高胆固醇饲料喂养雄性新西兰大白兔,建立AD家兔模型。模型建立后,用50 mg/(kg.d)EGB761灌... [目的]观察银杏叶提取物EGB761对阿尔茨海默(AD)病家兔模型胆固醇酰基转移酶(ACAT1)和卵磷脂-胆固醇酰基转移酶(LCAT)mRNA表达的影响。[方法]以2%高胆固醇饲料喂养雄性新西兰大白兔,建立AD家兔模型。模型建立后,用50 mg/(kg.d)EGB761灌胃3周作为EGB761组,以5 mg/(kg.d)辛伐他汀作为阳性药对照组。干预结束后,通过实时定量逆转录-聚合酶链反应(RT-PCR)法检测海马卵磷脂-胆固醇酰基转移酶mRNA和胆固醇酰基转移酶1 mRNA的表达。[结果]银杏叶提取物EGB761可以下调ACAT1 mRNA的表达,不影响LCAT mRNA的表达。[结论]银杏叶提取物EGB761可下调AD家兔模型ACAT1 mRNA表达,对LCAT mRNA表达无调节作用。 展开更多
关键词 银杏叶提取物EGB761 阿尔茨海默病 卵磷脂-胆固醇酰基转移酶 胆固醇酰基转移酶1
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部